The import of Remdesivir, with the commercial name Covifor, which is used to treat patients infected with COVID-19, has been authorized by the Medicines and Medical Devices Agency. The medicine will be supplied to Moldova by “Dita EstFarm” SRL in 10-20 days, in the quantity of about 2,000 vials, IPN reports.
In a press release, the Agency said Remdesivir is the first medicine authorized in the U.S. and the EU for treating COVID-19.
According to the Agency’s head Eremei Priseajniuc, for the Moldovans to have access to the most efficient drugs used in the treatment of COVID-19, the Medicines and Medical Devices Agency cooperates with world-renowned medicine producers and distributors, clinical research and medical development companies. “This way, we are moving towards the achievement of the set goal – to ensure the country’s pharmaceutical security during the pandemic,” he stated.
In Moldova, the use of Remdesivir is stipulated in the national clinical temporary protocol concerning the novel coronavirus for treating patients with SARS COV-2.
